#Japan #Osaka #Shionogi Healthcare #Sedes® Hi-G #Pain Reliever

Introduction to Sedes® Hi-G

In an exciting development for health-conscious consumers, Shionogi Healthcare Co., Ltd., based in Osaka, Japan, has announced the launch of a new packaging option for its popular pain reliever Sedes® Hi-G. Starting from September 2, 2025, the 18-pack version of this medication will be available for purchase. Sedes® Hi-G is classified as a designated second-class medical product and contains the same active ingredients found in prescription medications, aimed at providing effective relief for headaches and other pains.

Key Features of Sedes® Hi-G

1. Same Active Ingredients as Prescription Medications

Sedes® Hi-G stands out in the over-the-counter medication market for its formulation that mirrors prescription-strength pain relief. It includes four effective components:

• - Isopropyl Antipyrine (IPA): This ingredient acts directly on the central nervous system to reduce pain by suppressing the production of prostaglandins in peripheral tissues.
• - Acetaminophen: Well-known for its effectiveness, it not only alleviates pain but also helps in lowering fever.
• - Allylisopropylacetylurea: This ingredient aids in calming feelings of tension, excitement, and irritability, further enhancing overall pain-relieving effects.
• - Anhydrous Caffeine: Beyond its stimulating properties, caffeine assists in mitigating headaches and fatigue, offering an additional layer of comfort.

The combination of these ingredients makes Sedes® Hi-G a potent option for those seeking quick relief from various types of pain, particularly headaches.

2. Quick-Dissolving Granule Form

Sedes® Hi-G is available in a granular form that dissolves rapidly, catering to individuals who may have difficulty swallowing tablets. This granule format not only enhances the ease of consumption but has also contributed to the product’s popularity. Notably, the repeat purchase rate of Sedes® Hi-G has reached an impressive 49.2%, significantly outperforming the average repeat rate of 33% for competing fever-reducing analgesics in the same category for the fiscal year 2024-2025.

3. Convenient Individual Packaging

The new individual packaging of Sedes® Hi-G is designed for convenience. Each packet is easy to carry, making it perfect for travel or daily use. Consumers can take as many packets as needed, ensuring they are never without effective pain relief while on the go.

Commitment to ESG Management

Shionogi Healthcare is dedicated to environmental, social, and governance (ESG) standards, striving to grow alongside society. The company is aligned with the United Nations' Sustainable Development Goals (SDGs), focusing on health, economic growth, and reducing inequalities. Various initiatives are in place to address societal issues through healthcare and awareness programs.

Engaging Media and Accessibility

To promote health literacy and proactive self-care, Shionogi Healthcare actively utilizes its owned media channels and social media platforms. Through its website and official social media accounts (including X, Instagram, and LINE), the company shares valuable information, product campaigns, and self-care tips from experts, helping individuals implement correct and accessible self-care practices.

About Shionogi Healthcare

Founded as a subsidiary of the Shionogi Group, Shionogi Healthcare believes in transforming healthcare through innovative pharmaceutical approaches. Their mission, encapsulated in the motto of providing accessible and effective self-care for everyone, reflects their commitment to changing the landscape of everyday healthcare products.

Company Details:

• - Company Name: Shionogi Healthcare Co., Ltd.
• - Established: January 15, 2016
• - Headquarters: Yodoyabashi Square 7th Floor, 2-6-18 Kitahama, Chuo-ku, Osaka, Japan
• - Website: Shionogi Healthcare

Keep an eye out for the new 18-pack of Sedes® Hi-G, launching this fall, and experience the effective relief it offers.